Spike protein of SARS-COV-2 as a potential target for phytochemical constituents: A literature review
Abstract
SARS-CoV-2 belongs to well-known SARS Coronaviridae family. One of the main structural proteins of SARS-CoV-2 is the spike protein that is present around the surface of a viral cell and plays an essential role in viral attachment, fusion and invasion in host cell. Once a virus invades a cell, it replicates and infects other cells. The fundamental role of spike protein in the progression of viral infection has led to an increased interest in exploring agents that target the viral spike protein for effective control of CoVID-19. The related data from published articles reviewed and numerous phytochemicals that reportedly target the spike proteins of coronaviruses by computational studies briefly discussed. These active constituents possess the potential to develop as therapeutic and antiviral agents against SARS-CoV-2.
Downloads
References
Goel S, Goel A. COVID-19 evolution and alternative medicine—A review. J Pure Appl Microbiol. 2020; 14(suppl 1):841-8.
DOI: https://doi.org/10.22207/jpam.14.spl1.21
Basu A, Sarkar A, Maulik U. Computational approach for the design of potential spike protein binding natural compounds in SARS-CoV2. 2020.
DOI:https://doi.org/10.21203/rs.3.rs-33181/v1
Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2021; 39(9):3409-18.DOI: https://doi.org/10.1080/07391102.2020.1758788
Chen J, Li LF, Hu XR, Wei F, Ma S. Network Pharmacology-Based Strategy for Elucidating the Molecular Basis Forthe Pharmacologic Effects of Licorice (Glycyrrhiza spp.). Front Pharmacol. 2021; 12:872.
DOI: https://doi.org/10.3389/fphar.2021.590477
Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. npj Vaccines. 2021; 6(1):1-3.
DOI: https://doi.org/10.1038/s41541-021-00369-6
Jani V, Koulgi S, Uppuladinne VM, Sonavane U, Joshi R. An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2–Spike complex of SARS-CoV-2 using computational methods. Chemical Papers. 2021; 8:1-24.
DOI: https://doi.org/10.1007/s11696-021-01680-1
Kadioglu O, Saeed M, Greten HJ, Efferth T. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Comput Biol Med. 2021; 133:104359.
DOI: https://doi.org/10.1016/j.compbiomed.2021.104359
Kiran G, Karthik L, Devi MS, Sathiyarajeswaran P, Kanakavalli K, Kumar KM, et al. In silico computational screening of Kabasura Kudineer-official Siddha formulation and JACOM against SARS-CoV-2 spike protein. J Ayurveda Integr Med. 2020.
DOI: https://doi.org/10.1016/j.jaim.2020.05.009
Kulkarni SA, Nagarajan SK, Ramesh V, Palaniyandi V, Selvam SP, Madhavan T. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. J Mol Struct. 2020; 1221:128823.
DOI: https://doi.org/10.1016/j.molstruc.2020.128823
Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016; 3:237-61.
DOI: https://doi.org/10.1146/annurev-virology-110615-042301
Maurya DK. Evaluation of Yashtimadhu (Glycyrrhiza glabra) active phytochemicals against novel coronavirus (SARS-CoV-2). 2020.
DOI: https://doi.org/10.21203/rs.3.rs-26480/v1
Nadeem MS, Zamzami MA, Choudhry H, Murtaza BN, Kazmi I, Ahmad H, et al. Origin, potential therapeutic targets and treatment for coronavirus disease (COVID-19). Pathogens. 2020; 9(4):307.
DOI: https://doi.org/10.3390/pathogens9040307
Orhan IE, Deniz FS. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2?. Nat Prod Bioprospect. 2020; 10(4):171-86.
DOI: https://doi.org/10.1007/s13659-020-00250-4
Panati K, Narala VR. COVID-19 outbreak: an update on therapeutic options. SN Compr Clin Med. 2020; 2(4):379-80.
DOI: https://doi.org/10.1007/s42399-020-00264-6
Pandey P, Rane JS, Chatterjee A, Kumar A, Khan R, Prakash A, et al. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. J Biomol Struct. 2021; 39(16):6306-16.
DOI: https://doi.org/10.1080/07391102.2020.1796811
Prasad SK, Pradeep S, Shimavallu C, Kollur SP, Syed A, Marraiki N, et al. Evaluation of Annona muricata acetogenins as potential anti-SARS-CoV-2 agents through computational approaches. Front Chem. 2020; 8.
DOI: https://doi.org/10.3389/fchem.2020.624716
Rajan KA, Muthusamy VS, Ramanathan M. Phytomolecules having flavone and napthofuran nucleus exhibited better binding G-score against protease and SPIKE protein of novel corona virus COVID-19. 2020. Preprint
Ranjan P, Mohapatra B, Das P. A rational drug designing: What bioinformatics approach tells about the wisdom of practicing traditional medicines for screening the potential of Ayurvedic and natural compounds for their inhibitory effect against COVID-19 Spike, Indian strain Spike, Papain-like protease and Main Protease protein. 2020. Preprint.
DOI: https://doi.org/10.21203/rs.3.rs-30366/v1
Sayed AM, Khattab AR, AboulMagd AM, Hassan HM, Rateb ME, Zaid H, et al. Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale. RSC Advances. 2020; 10(34):19790-802.
DOI: https://doi.org/10.1039/D0RA04199H
Shahid MA, Chowdhury MA, Kashem MA. Scope of Natural Plant Extract to Deactivate COVID-19. 2020.
DOI: https://doi.org/10.21203/rs.3.rs-19240/v1
Sinha SK, Prasad SK, Islam MA, Gurav SS, Patil RB, AlFaris NA, et al. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J Biomol Struct Dyn. 2020; 17:1-15.
DOI: https://doi.org/10.1080/07391102.2020.1779132
Tabari MA, Khoshhal H, Tafazoli A, Khandan M, Bagheri A. Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic. Inform Med Unlocked. 2020; 21:100458.
DOI: https://doi.org/10.1016/j.imu.2020.100458
Utomo RY, Ikawati M, Meiyanto E. Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection. Preprint. 2020.
DOI: https://doi.org/10.20944/preprints202003.0214.v1
Wang D, Huang J, Yeung AW, Tzvetkov NT, Horbańczuk JO, Willschke H, et al. The significance of natural product derivatives and traditional medicine for COVID-19. Processes. 2020; 8(8):937.
DOI: https://doi.org/10.3390/pr8080937
World Health Organization, 2021. Weekly epidemiological update on COVID-19 - 2 November 2021.
Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020; 16(10):1708-17.
DOI: https://doi.org/10.7150/ijbs.45538
Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020; 14(2):126-35.
Copyright (c) 2021 Journal of Shifa Tameer-e-Millat University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Shifa Tameer-e-Millat University (JSTMU) is the owner of all copyright to any work published in the journal. Any material printed in JSTMU may not be reproduced without the permission of the editors or publisher. The Journal accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing and/or decision in this journal. The Editorial Board makes every effort to ensure the accuracy and authenticity of material printed in the journal. However, conclusions and statements expressed are views of the authors and do not necessarily reflect the opinions of the Editorial Board or JSTMU.
Content of this journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
